Streptococcus pneumoniae infections in people with diabetes are associated with increased mortality and morbidity.
For people with diabetes, vaccination against pneumococcal disease is recommended by:
• the Australian Immunisation Handbook 9thEdition 2008 (National Health and Research Council), and
• the Diabetes Management in General Practice 2010/11 Guidelines for Type 2 Diabetes (Diabetes Australia in conjunction with the RACGP).
Currently, it is estimated that fewer than 10% of patients aged 10 to 64 years at increased risk of invasive pneumococcal disease (including people with diabetes) have been vaccinated with pneumococcal vaccine. As a result CSL has been working with the Australian Diabetes Educators Association to help people with diabetes reduce their risk of pneumococcal disease.
Read more here.
Click here to visit the website.